65.4 F
Fort Worth
Saturday, September 19, 2020
- Advertisements -
Health Care Shkreli pleads not guilty to hiding Retrophin holdings

Shkreli pleads not guilty to hiding Retrophin holdings

Other News

Exxon’s oil slick

Exxon Mobil is slashing its capital spending budget for 2020 by 30% due to weak demand caused by the COVID-19 pandemic and a market...

Folk music’s Mark Twain: 7 Essential tracks from John Prine,

NEW YORK (AP) — Some people, the songs just come out of them. For nearly half a century, they tumbled out of John Prine...

Tarrant County records another COVID-19 death

Tarrant County Public Health (TCPH) on Wednesday, April 8 reported that a resident of Euless has died as the result of the COVID-19 virus....

Tradition stymied: A year unlike any since WWII for Augusta

The Masters is so intertwined with Augusta, they added an extra day to spring break.You see, the first full week of April isn't just...

Former drug company executive Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.

The 33-year-old founder of Retrophin and Turing Pharmaceuticals entered his plea on Monday in Brooklyn federal court to the new charge in a securities fraud case.

Standing beside his lawyer Ben Brafman in a dark blazer, stone-colored pants and no tie, Shkreli loudly answered “yes, your honor,” when U.S. District Judge Kiyo Matsumoto asked if he had reviewed the allegations. When he asked how he pleaded he responded with equal force: “Not guilty.”

Former corporate lawyer Evan Greebel, who is accused of aiding Shkreli in his schemes, also pleaded not guilty to the new charge. Although prosecutors asked to schedule a trial date in February, the judge agreed to put off deciding a date until Shkreli and Greebel have had more time to review evidence and the new allegations.

Brafman told the judge that Shkreli is still considering whether to use a “reliance-of-counsel” defense, in which he might seek to blame Greebel for his actions.

The brash former executive, known to lash out at journalists and critics on Twitter, was arrested in December and accused of defrauding investors in hedge funds he ran and using $11 million in Retrophin assets to pay them off. In a new indictment filed Friday, he is also accused of secretly hiding his control of unrestricted stock in the company, which prosecutors allege he used to help satisfy his debts.

While CEO of Turing Pharmaceuticals, Shkreli rose to infamy last year when the company raised the price of a rare treatment for a potentially deadly infection by more than 5,000 percent. Although the criminal case has nothing to do with the price increase, Shkreli has said he was targeted by prosecutors because of his notoriety.

Speaking outside the courthouse following a short hearing, Brafman told reporters that he doesn’t think the new charge “adds anything of value” to the government’s case.

Shkreli and Greebel are scheduled to appear in court again on July 14.

- Advertisements -
- Advertisements -

Latest News

Tarrant County reports four COVID deaths on Friday

Tarrant County Public Health reported four COVID-19 deaths on Friday, Sept. 18. The deceased include a man from Hurst in his 80s,...

3 more COVID cases linked to American’s bar crawl in Bavaria

By FRANK JORDANS and DAVID RISING Associated PressBERLIN (AP) — Authorities in southern Germany have recorded three more COVID-19 infections in people...

Tarrant County reports 4 COVID deaths on Thursday

 Tarrant County Public Health reported four COVID-19 deaths on Thursday, Sept. 17. The deceased include a man from Fort Worth in his...

MedStar offers onsite flu vaccine clinics

With the presence of COVID-19, there is additional concern about this year’s flu season, the City of Fort Worth said in a...

Tarrant County reports 7 COVID deaths on Tuesday and Wednesday

Tarrant County Public Health reported four COVID-19 deaths on Wednesday and three on Tuesday.The deceased include a man from Fort Worth in...